About: Community Clinical Research

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Community Clinical Research Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

facility in Austin, United States

Attributes	Values
rdf:type	Item
description	facility in Austin, United States (en)
rdfs:label	Community Clinical Research (en)
skos:prefLabel	Community Clinical Research (en)
name	Community Clinical Research (en)
ROR ID	wds:Q30269707-742673E6-87B0-4B9E-BA8E-BFDBB3D97A5A
ROR ID	01chgch18
instance of	wds:Q30269707-7C1B8E2A-A8F0-4C33-B90A-55B39907B3F1
instance of	facility
country	wds:Q30269707-F20F6853-4103-4045-A523-85363EAFC610
country	United States of America
Ringgold ID	wds:Q30269707-17C7855B-AB4B-4EEF-AA32-5DD05F99AF39
Ringgold ID	90539
inception	wds:Q30269707-EAEF8D7D-DF09-4D27-918E-06DC269DFDF4
inception	1994-01-01 00:00:00Z (xsd:dateTime)
skos:altLabel	CCR (en)
located in the adm...erritorial entity	wds:Q30269707-53FEE0FA-01DC-4B8F-8959-313C7FD97974
ISNI	wds:Q30269707-C5F24A56-E84E-4805-9C36-F8DFC02532F5
coordinate location	wds:Q30269707-455800CA-03E7-4D60-9B9E-2CCA7B7EAB1B
official website	wds:Q30269707-1F297498-957F-41EC-B3CB-B75E209F4797
located in the adm...erritorial entity	Austin
ISNI	000000040625604X
coordinate location	POINT(-97.67537 30.335827)
official website	http://www.communityclinical.com/
GRID ID	wds:Q30269707-FC7CDD6C-3954-465A-AA1E-064318B00D45
GRID ID	grid.477129.e
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30269707
is research site of	Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia A Study of Aripiprazole in Patients With Major Depressive Disorder Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year Crossover Bioequivalence Study of Quetiapine Fumarate 300 mg Tablets Under Steady State Fasted Conditions A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) Study Comparing Outcomes for Patients With Treatment Resistant Depression Who Receive VNS Therapy at Different Doses Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression A Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Participants With Negative Symptoms of Schizophrenia Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder TC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in Schizophrenia Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia PEARL Schizophrenia Maintenance Switching to Iloperidone From Other Antipsychotics in Schizophrenia A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder A Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients A Twelve Week, Open Label Extension Study in Patients With Schizophrenia A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
is research site of	wds:Q63815678-C6F6A0DD-E780-420A-9D85-C529C164F791 wds:Q63397063-3F6EF1B8-5BC9-47D1-936F-74D495848661 wds:Q64599903-D1A22C80-A49B-4975-A085-7ECDE85CF413 wds:Q64030187-770371A1-B6D5-4B94-B4A2-B6D170776D2F wds:Q62105804-9F266E01-A4B8-4DBD-A000-8494A1FC2457 wds:Q64676643-6B07C3D8-0D73-4379-9F13-F318C2043043 wds:Q63812026-9F9A5412-2BF6-49B2-9B89-0D7292EFC27D wds:Q63316723-DFE30B95-FC99-4E04-869C-6969C86F5E0F wds:Q64188318-C6522B19-C3F0-4E82-9B49-ED04992258F5 wds:Q65332642-CD67290B-C636-412B-8A11-C79A9F4D75FB wds:Q65474672-A7910B6B-08D3-4441-BA94-5C9D7537845D wds:Q64622334-D12819C6-3E54-45DC-97E1-DFBF41212EE3 wds:Q63335122-5933EF11-0E46-49A0-874B-77875CF55E58 wds:Q64805347-F4185C22-0E6C-47EB-8378-48DE5B03CD2D wds:Q64709284-163DA9F2-83F7-4736-AED7-C10827410E1E wds:Q64660814-9EA024EF-D1FC-4AEB-9F5C-05355865965F wds:Q64723540-63253026-FDCA-48DB-ADDA-CC1CA05CF794 wds:Q63598092-BD5BF31C-EBC5-439D-99B8-BF71940A0E76 wds:Q64392402-A66F4200-66AA-4F94-A948-9E706FEC6D61 wds:Q63395042-3F16BA03-3E2F-46B3-8C72-E20BDC63ABDF wds:Q64647936-9D05E945-6C97-4395-934F-92FD1C4D6D95 wds:Q64654293-65BCD318-B5BD-4D85-B43D-2FCAA7D41E41 wds:Q64836942-ED5720F6-561D-4E35-8FD6-4CC1C100078A wds:Q63580052-4515B711-D325-47C8-A031-9685ADF9BF33 wds:Q66077067-10FAB1AA-10CB-4FAA-93B7-CA8A0646CFB1 wds:Q63813566-3F9C2A2E-A301-4909-B14B-9493BE7C9FF8 wds:Q64611666-EEF8A83D-5874-4385-A9DF-FAACA03E989F wds:Q66079724-B454B188-5903-418E-8249-B00108BD0F83 wds:Q63318493-E5F642A9-8394-42D0-99BA-FCB76C02F082 wds:Q63571079-A95B7391-1EB2-40B8-9B88-76B3A729C97A wds:Q61914794-9E6D8B0D-12EA-4DB5-A159-A8BBC2D4C09D wds:Q65353377-36FF327A-5B1C-4A26-8054-14928C86A3A0 wds:Q64139986-DEB6EBD5-5407-4891-A5DB-096D3827EEE3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software